Expression alteration of Neuroligin family gene in attention deficit and hyperactivity disorder and autism spectrum disorder.

[1]  A. Grace,et al.  Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment , 2022, Molecular Psychiatry.

[2]  Arvin Haghighatfard,et al.  FOXP2 down expression is associated with executive dysfunctions and electrophysiological abnormalities of brain in Autism spectrum disorder; a neuroimaging genetic study , 2022, Autism & developmental language impairments.

[3]  Arvin Haghighatfard,et al.  Detection of six novel de novo mutations in individuals with low resilience to psychological stress , 2021, PloS one.

[4]  A. Ghaderi,et al.  Gene expression study of mitochondrial complex I in schizophrenia and paranoid personality disorder , 2018, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[5]  Arvin Haghighatfard,et al.  Neuregulin1 types mRNA level changes in autism spectrum disorder, and is associated with deficit in executive functions , 2018, EBioMedicine.

[6]  Arvin Haghighatfard,et al.  Low resilience to stress is associated with candidate gene expression alterations in the dopaminergic signalling pathway , 2018, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

[7]  Masahiko Watanabe,et al.  Dopamine synapse is a neuroligin-2–mediated contact between dopaminergic presynaptic and GABAergic postsynaptic structures , 2016, Proceedings of the National Academy of Sciences.

[8]  S. Nelson,et al.  Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders , 2015, Neuron.

[9]  Parag Mallick,et al.  Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion , 2015, Cell.

[10]  R. Gao,et al.  Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disorders. , 2015, Current molecular medicine.

[11]  Z. Warren,et al.  Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014 , 2018, Morbidity and mortality weekly report. Surveillance summaries.

[12]  M. Gill,et al.  Investigating the Contribution of Common Genetic Variants to the Risk and Pathogenesis of ADHD , 2012, The American journal of psychiatry.

[13]  G. Boulianne,et al.  Neurexins and Neuroligins: Recent Insights from Invertebrates , 2011, Molecular Neurobiology.

[14]  A. Thapar,et al.  Fitting the pieces together: current research on the genetic basis of attention-deficit/hyperactivity disorder (ADHD) , 2010, Neuropsychiatric disease and treatment.

[15]  Gary D Bader,et al.  Functional impact of global rare copy number variation in autism spectrum disorders , 2010, Nature.

[16]  J. Hutsler,et al.  Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders , 2010, Brain Research.

[17]  P. Patterson.  Immune involvement in schizophrenia and autism: Etiology, pathology and animal models , 2009, Behavioural Brain Research.

[18]  T. Südhof.  Neuroligins and neurexins link synaptic function to cognitive disease , 2008, Nature.

[19]  Edwin H. Cook,et al.  Copy-number variations associated with neuropsychiatric conditions , 2008, Nature.

[20]  E. Phelps,et al.  Neural mechanisms mediating optimism bias , 2007, Nature.

[21]  Fikret Erdogan,et al.  Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. , 2007, Human molecular genetics.

[22]  T. Südhof,et al.  Activity-Dependent Validation of Excitatory versus Inhibitory Synapses by Neuroligin-1 versus Neuroligin-2 , 2007, Neuron.

[23]  K. Lesch,et al.  Co-morbidity of adult attention-deficit/hyperactivity disorder with focus on personality traits and related disorders in a tertiary referral center , 2007, European Archives of Psychiatry and Clinical Neuroscience.

[24]  Charles E. Schwartz,et al.  High frequency of neurexin 1β signal peptide structural variants in patients with autism , 2006, Neuroscience Letters.

[25]  M. Merzenich,et al.  Model of autism: increased ratio of excitation/inhibition in key neural systems , 2003, Genes, brain, and behavior.

[26]  Thomas Bourgeron,et al.  Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism , 2003, Nature Genetics.

[27]  R. Fetter,et al.  Neuroligin Expressed in Nonneuronal Cells Triggers Presynaptic Development in Contacting Axons , 2000, Cell.

[28]  J. Gregg,et al.  Gene expression changes in children with autism. , 2008, Genomics.